Longvida Optimized Curcumin® was designed by university neuroscientists to bypass initial hydrolysis and deliver bioefficacious levels of unglucuronidated (free) curcumin to the brain and throughout the entire body.
Exclusively licensed to Verdure Sciences®, patented Solid Lipid Curcumin Particle (SLCP™) Technology enables the uptake of free curcumin to the blood and target tissues. Extensively studied by independent researchers globally, Longvida Optimized Curcumin® is able to cross the blood-brain barrier, offering efficacious amounts of free curcumin at easily managed daily doses.
Multiple clinical findings show that Longvida Optimized Curcumin® delivers free curcumin to target tissues. Studied extensively by independent academic and medical centers globally, Longvida® offers a 7.5 hour half-life, compared to the 2-3 hour half-life of standard curcumin.
Longvida Optimized Curcumin® was designed by university neuroscientists to bypass initial hydrolysis and deliver bioefficacious levels of unglucuronidated (free) curcumin to the brain and throughout the entire body.
Exclusively licensed to Verdure Sciences®, patented Solid Lipid Curcumin Particle (SLCP™) Technology enables the uptake of free curcumin to the blood and target tissues. Extensively studied by independent researchers globally, Longvida Optimized Curcumin® is able to cross the blood-brain barrier, offering efficacious amounts of free curcumin at easily managed daily doses.
Multiple clinical findings show that Longvida Optimized Curcumin® delivers free curcumin to target tissues. Studied extensively by independent academic and medical centers globally, Longvida® offers a 7.5 hour half-life, compared to the 2-3 hour half-life of standard curcumin.
Non-GMO compliant; meets or exceeds
USP / ICH / Prop-65 standards
Acute & subacute toxicology
data published
Self-GRAS
Determination
US Patent 9192644, EP Patent 1993365
Additional patents pending
RESEARCH BEHIND LONGVIDA®
Researchers with the University of Colorado clinically investigated Longvida’s ability to improve vascular endothelial function, as assessed by endothelium dependent dilation (EDD), in middle-aged and older adults. After 12 weeks of 2000mg per day of Longvida Optimized Curcumin®, brachial artery flow-mediated dilation (FMDba) was increased by 36% versus placebo, which showed no change. Results, published in January 2017, indicate that Longvida® improves vascular endothelial function by increasing nitric oxide bioavailability through a reduction in oxidative stress and inflammatory signaling in middle-aged and older adults. According to the authors, these results support evidence that supplementation of Longvida® may be a promising therapeutic option to improve vascular health. Further, this clinical provides additional support for Longvida’s efficacious ability to promote healthy aging.
From the farm to standardized extract, each part of the process is met with strict quality assurance and control parameters with traceability and sustainability measures held in high esteem to ensure consistency for the global market through our Verdugration® initiative. Longvida® is supported with extensive traceability and sustainability initiatives farmed and harvested by experienced farmers. Longvida’s turmeric supports these established relationships with a focus on ethics and quality standards.
Longvida® has received recognition for the rigorous scientific support and proven efficacy as an optimized curcumin extract that delivers beneficial support for a wide variety of tangible health applications. It has earned multiple industry awards and global accreditation for groundbreaking research initiatives including receiving the NutraIngredients University Research of the Year Award in 2015, recognition as the NutraIngredients Nutrition Research Project of the Year Finalist 2018 and receiving the NutraIngredients Nutrition Research Project of the Year Award in 2019. Longvida® is also batch-verified for sports banned substances by Korva Labs, is non-GMO Project Verified, and Certified Glyphosate Residue Free.
Longvida Optimized Curcumin® was designed by university neuroscientists to survive initial digestion and deliver free curcumin and metabolites to the brain and throughout the body using Solid Lipid Curcumin Particle™ (SLCP™) Technology. SLCP™ enables the uptake of free curcumin to the blood and target tissues; inspired by traditional use. Extensively studied by independent researchers globally, Longvida Optimized Curcumin® is able to cross the blood brain and blood retinal barriers, offering efficacious free curcumin at easily managed daily doses.
For nearly 15 years, Longvida® has been the safe, efficacious, clinically supported Cognitive Curcumin of Choice™. Accredited by university researchers, and backed by more than 30 human clinical studies, Longvida® is well-established as a globally accepted curcumin with a long-standing history of efficacy, safety, and trust. In addition to efforts to exceed global regulatory compliance, Longvida® Optimized Curcumin® and SLCP™ Technology are protected by global intellectual property and multiple patents.
RESEARCH BEHIND LONGVIDA®
Researchers with the University of Colorado clinically investigated Longvida’s ability to improve vascular endothelial function, as assessed by endothelium dependent dilation (EDD), in middle-aged and older adults. After 12 weeks of 2000mg per day of Longvida Optimized Curcumin®, brachial artery flow-mediated dilation (FMDba) was increased by 36% versus placebo, which showed no change. Results, published in January 2017, indicate that Longvida® improves vascular endothelial function by increasing nitric oxide bioavailability through a reduction in oxidative stress and inflammatory signaling in middle-aged and older adults. According to the authors, these results support evidence that supplementation of Longvida® may be a promising therapeutic option to improve vascular health. Further, this clinical provides additional support for Longvida’s efficacious ability to promote healthy aging.